CSIMarket
 


Panbela Therapeutics Inc   (PBLA)
Other Ticker:  
 
 

PBLA's Net Income Growth by Quarter and Year

Panbela Therapeutics Inc 's Net Income results by quarter and year




PBLA Net Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - -4.74 -3.55 -0.88
III Quarter September - -4.40 -2.14 -1.67
II Quarter June - -22.13 -2.19 -0.42
I Quarter March -5.11 -3.67 -2.26 -1.80
FY   -5.11 -34.94 -10.14 -4.77



PBLA Net Income first quarter 2023 Y/Y Growth Comment
Panbela Therapeutics Inc in the first quarter 2023 recorded net loss of $ -5.11 millions.

According to the results reported in the first quarter 2023, Panbela Therapeutics Inc achieved the best Net Income growth in Major Pharmaceutical Preparations industry. While Panbela Therapeutics Inc ' s Net Income no change of % ranks overall at the positon no. in the first quarter 2023.




PBLA Net Income ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Panbela Therapeutics Inc 's first quarter 2023 Net Income $ -5.11 millions PBLA's Income Statement
Panbela Therapeutics Inc 's first quarter 2022 Net Income $ -3.67 millions Quarterly PBLA's Income Statement
New: More PBLA's historic Net Income Growth >>


PBLA Net Income (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Income first quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income first quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Panbela Therapeutics Inc 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PBLA's I. Quarter Q/Q Net Income Comment
Recent results of -5.11 millions by Panbela Therapeutics Inc come out even worse if you take a look at -4.74 millions net loss in the fourth quarter.

Within Major Pharmaceutical Preparations industry Panbela Therapeutics Inc achieved highest sequential Net Income growth. While Panbela Therapeutics Inc 's Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PBLA's I. Quarter Q/Q Net Income Comment
Current accomplishment of -5.11 millions by Panbela Therapeutics Inc come out even more unfavourable compare to the net loss -4.74 millions in the previous quarter.

Within Major Pharmaceutical Preparations industry Panbela Therapeutics Inc achieved highest sequential Net Income growth. While Panbela Therapeutics Inc 's Net Income growth quarter on quarter, overall rank is .


Panbela Therapeutics Inc 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
Cumulative Net Income 12 Months Ending $ -36.38 $ -34.93 $ -33.75 $ -31.49 $ -11.54
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #




Cumulative Net Income growth Comment
Panbela Therapeutics Inc ' has realized cumulative trailing twelve months net loss of $ -36 millions in the Mar 31 2023 period.
The situation is getting worse as the cumulative net loss is inflating from $ -34.93 millions in the twelve months ending a quarter before and $ -10.135 millions for the twelve months ending in the quarter a year ago Thomas  Clarke mentioned.

Panbela Therapeutics Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment
Panbela Therapeutics Inc ' has realized cumulative trailing twelve months net loss of $ -36 millions in the Mar 31 2023 period.
The situation is detiriorating as the cumulative net loss is inflating from $ -34.93 millions in TTM ending quarter Dec 31 2022 and $ -10.135 millions from the TTM period ending Mar 31 2022.

Panbela Therapeutics Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Income Growth
Major Pharmaceutical Preparations Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
PBLA's Net Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for PBLA's Competitors
Net Income Growth for Panbela Therapeutics Inc 's Suppliers
Net Income Growth for PBLA's Customers

You may also want to know
PBLA's Annual Growth Rates PBLA's Profitability Ratios PBLA's Asset Turnover Ratio PBLA's Dividend Growth
PBLA's Roe PBLA's Valuation Ratios PBLA's Financial Strength Ratios PBLA's Dividend Payout Ratio
PBLA's Roa PBLA's Inventory Turnover Ratio PBLA's Growth Rates PBLA's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Mar 31 2023 within Healthcare SectorY/Y Change %Net Income for the quarter ending Mar 31 2023
Electromed Inc 66.67%$ 66.667 millions
Select Medical Holdings Corp52.45%$ 52.446 millions
Addus Homecare Corporation49.65%$ 49.646 millions
Semler Scientific inc 47.89%$ 47.887 millions
Fonar Corporation37.49%$ 37.492 millions
Harmony Biosciences Holdings inc 37.24%$ 37.235 millions
Iradimed Corporation36.97%$ 36.971 millions
Resmed Inc 29.88%$ 29.880 millions
Option Care Health Inc 29.51%$ 29.506 millions
Globus Medical Inc 29.00%$ 29.002 millions
Bruker Corporation24.64%$ 24.638 millions
Ensign Group Inc19.73%$ 19.727 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071